Photo credit: Biolinq

By Laura Lovett 01:39 pm March 28, 2019
This morning Biolinq, a digital health company specializing in minimally invasive continuous glucose monitoring, raised $4.75 million in extended Series A financing. This new capital was led by JDRF T1D Fund, Aphelion Capital and LifeSci Venture Partners.  This latest funding announcement will build on the $10 million the company raised in November of 2017, bringing the total Series A capital to...